Glaxo’s ChinaGate: Sexual Desires And Bribes By The Prescription

esilverman And now, we bring the latest developments in the Glaxo bribery scandal. The drugmaker has shifted Herve Gisserot, senior vp of its European business, to oversee ...

Forest Labs wins FDA approval for antidepressant Fetzima

Ryan McBride Forest Laboratories took another step forward in rebuilding its antidepressant business with the FDA's approval of Fetzima for major depressive disorder (MDD) in adults. ...

Gilead earnings firm, but company gets shot in arm from Vertex setback

Eric Palmer Gilead Sciences turned in second-quarter earnings that were pretty much in line with analysts' projections Thursday, then caught a break in the same day that pushed ...

Merck Issues Statement on CHMP Review of Diabetic Therapies

mia.burns Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin WHITEHOUSE STATION, N.J.– July 26, 2013–(BUSINESS ...

EMA finds GLP-1 diabetes drugs safe to use

Eric Palmer Earlier this year, a study linked the GLP-1 class of drugs for Type 2 diabetes to an increased risk of pancreatic cancer. Today, the European Medicines Agency said the data ...

EMA Decides That Diabetes Drug Are Not Linked To Pancreatic Cancer

esilverman In a decision that is a big boost to several drugmakers, the European Medicines Agency has concluded that there is no evidence to confirm recent concerns that a ...

GlaxoSmithKline, Biogen Idec strike antibody deals with biotech startup Adimab

Ryan McBride Adimab has landed its two biggest licensing deals to date, and the undisclosed payments from the pacts have pushed its antibody-discovery business far into profitability. FierceBiotech ...

Up And Down The Ladder… Job Changes

esilverman Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s ...

FDA Approves Fetzima for MDD in Adults

mia.burns Forest Laboratories and Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Disorder in Adults NEW YORK & CASTRES, ...

Gilead Sciences 2Q profit grows 8 percent

mia.burns FOSTER CITY, Calif. (AP) — HIV drugmaker Gilead Sciences Inc. said Thursday that its second-quarter net income rose more than 8 percent on higher sales of its best-selling ...

Blue Cross Blue Shield of Michigan saves an estimated $155 million over three years from Patient-Centered Medical Home program

barbara.lempert Largest PCMH program in the nation yields improvements in quality and preventive care DETROIT, July 8, 2013 /PRNewswire/ — Blue Cross Blue Shield of Michigan ...

GAO Report: Private Health Insurance: The Range of Base Premiums in the Individual Market by State in January 2013

barbara.lempert What GAO Found GAO reported the range of base premiums prior to underwriting for health insurance in the individual market that were displayed on the HealthCare.gov ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS